New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce the risk of Alzheimer's disease and dementia.

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Established under President Joe Biden’s Inflation Reduction Act of 2022, the Medicare Drug Price Negotiation Program allows ...

Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

OK, I know my gig is positivity and being upbeat and all that, but for today I thought I’d rant on about something that irks ...

Meanwhile for diabetes patients the insulin Fiasp is $31.60 on the PBS, but Americans pay $930, while the medication Jardiance is $619 ... Minister Mark Butler said drug makers in the US ...

The innovator drug named Jardiance by BI costs around Rs 60 per tablet. Delhi-based Mankind Pharma launched a range of empagliflozin products, including its combinations, priced between Rs 5.5 and ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

Further research revealed that one of these drugs, DDL-920 – developed at UCLA, led to the complete recovery of movement control – something many stroke patients never regain.

unprocessed tobacco leaves waiting to be turned into the popular drug taba. Suddenly, her phone rings. A customer. She smiles knowingly. “She’s one of my favourites because she keeps coming ...